Compass Wealth Management LLC Has $731,000 Holdings in CVS Health Co. (NYSE:CVS)

Compass Wealth Management LLC cut its stake in shares of CVS Health Co. (NYSE:CVS) by 64.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,631 shares of the pharmacy operator’s stock after selling 21,183 shares during the quarter. Compass Wealth Management LLC’s holdings in CVS Health were worth $731,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of CVS. Pzena Investment Management LLC boosted its stake in CVS Health by 132.9% during the second quarter. Pzena Investment Management LLC now owns 12,936,388 shares of the pharmacy operator’s stock worth $764,023,000 after acquiring an additional 7,382,931 shares in the last quarter. Capital International Investors boosted its stake in CVS Health by 12.5% during the first quarter. Capital International Investors now owns 37,917,923 shares of the pharmacy operator’s stock worth $3,024,334,000 after acquiring an additional 4,226,225 shares in the last quarter. Capital World Investors boosted its stake in CVS Health by 8.0% during the first quarter. Capital World Investors now owns 43,776,874 shares of the pharmacy operator’s stock worth $3,491,643,000 after acquiring an additional 3,232,172 shares in the last quarter. State of Michigan Retirement System boosted its stake in CVS Health by 402.5% during the second quarter. State of Michigan Retirement System now owns 2,005,677 shares of the pharmacy operator’s stock worth $118,455,000 after acquiring an additional 1,606,500 shares in the last quarter. Finally, Swedbank AB bought a new position in CVS Health during the first quarter worth $110,816,000. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms have weighed in on CVS. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and raised their price objective for the company from $59.00 to $85.00 in a research note on Friday, October 4th. Truist Financial raised their price objective on shares of CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research note on Friday, October 11th. Barclays raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $63.00 to $82.00 in a research note on Thursday, October 10th. Wells Fargo & Company raised their price objective on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Nine investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $75.26.

CVS Health Trading Down 2.1 %

NYSE CVS opened at $63.67 on Friday. The stock has a market capitalization of $79.93 billion, a price-to-earnings ratio of 11.19, a PEG ratio of 0.93 and a beta of 0.54. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The business’s fifty day moving average is $59.73 and its 200-day moving average is $60.75.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the previous year, the business posted $2.21 EPS. Equities research analysts predict that CVS Health Co. will post 6.51 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be paid a $0.665 dividend. The ex-dividend date of this dividend is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.18%. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.